{
	"symbol": "EPRX",
	"name": "Eupraxia Pharmaceuticals Inc.",
	"price": 7.645,
	"priceChange": 0.255,
	"percentChange": 3.450609,
	"exchangeName": "Toronto Stock Exchange",
	"exShortName": "TSX",
	"exchangeCode": "TSX",
	"marketPlace": null,
	"sector": "Healthcare",
	"industry": "Biotechnology",
	"volume": 42810,
	"openPrice": 7.4,
	"dayHigh": 7.67,
	"dayLow": 7.2,
	"MarketCap": 274892053,
	"MarketCapAllClasses": 274068304,
	"peRatio": "",
	"prevClose": 7.39,
	"dividendFrequency": null,
	"dividendYield": null,
	"dividendAmount": null,
	"dividendCurrency": null,
	"beta": 1.550701,
	"eps": null,
	"exDividendDate": "",
	"longDescription": "Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product candidates address therapeutic areas with a high unmet medical need and strive to provide improved patient benefit by delivering targeted, long-lasting activity with fewer side effects. Its lead product candidate, EP-104IAR, is in development for the treatment of pain due to osteoarthritis of the knee. In addition, it is developing a pipeline of earlier-stage long-acting formulations.",
	"fulldescription": "Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product candidates address therapeutic areas with a high unmet medical need and strive to provide improved patient benefit by delivering targeted, long-lasting activity with fewer side effects. Its lead product candidate, EP-104IAR, is in development for the treatment of pain due to osteoarthritis of the knee. In addition, it is developing a pipeline of earlier-stage long-acting formulations.",
	"website": "http://www.eupraxiapharma.com",
	"email": "",
	"phoneNumber": "+1 250 590-3968",
	"fullAddress": "204 - 2590 Cadboro Bay Road, Victoria, BC, CA",
	"employees": "29",
	"shareOutStanding": 35957103,
	"totalDebtToEquity": "",
	"totalSharesOutStanding": 35849353,
	"sharesESCROW": null,
	"vwap": 7.48785046,
	"dividendPayDate": null,
	"weeks52high": 8.13,
	"weeks52low": 3.07,
	"alpha": 0.017934,
	"averageVolume10D": 48164,
	"averageVolume20D": 38713,
	"averageVolume30D": 34182,
	"averageVolume50D": 37024,
	"priceToBook": -64.7,
	"priceToCashFlow": -8.4,
	"returnOnEquity": -318.95,
	"returnOnAssets": -79.62,
	"day21MovingAvg": 6.153333,
	"day50MovingAvg": 5.7078,
	"day200MovingAvg": 4.78065,
	"dividend3Years": "",
	"dividend5Years": "",
	"datatype": "equity",
	"issueType": "CS",
	"close": 7.65,
	"qmdescription": "Biotechnology",
	"__typename": "Company"
}